Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2007
08/09/2007WO2005073722A3 Luminogenic and nonluminogenic multiplex assay
08/09/2007WO2004099432A3 Identification of biomarkers for detecting pancreatic cancer
08/09/2007WO2004087933A3 A novel encoding method for 'one-bead one-compound' combinatorial libraries
08/09/2007WO2004084802A3 Glycoconjugate sensors
08/09/2007WO2004069795A3 Diagnosis and treatment of chronic tissue damage
08/09/2007WO2003086176A3 Observation of effects of body fluids on indicator cells for disease diagnosis
08/09/2007US20070186299 Knockout mouse for the tumor suppressor gene ANX7
08/09/2007US20070186296 Cloning, characterization, and application of tnfrsf19 in neurological disorders
08/09/2007US20070186295 TAT-036 and methods of assessing and treating cancer
08/09/2007US20070186294 TAT-030 and methods of assessing and treating cancer
08/09/2007US20070186293 Rat embryonic stem cell
08/09/2007US20070186290 Diagnostic and therapeutic use of the human hif3alpha gene and proteins for neurodegenerative diseases
08/09/2007US20070185412 Method and apparatus for penetrating tissue
08/09/2007US20070185321 Growth differentiation factor-8
08/09/2007US20070185313 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
08/09/2007US20070185312 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction
08/09/2007US20070185201 Compositions and Methods for Preventing or Treating Inflammatory Bowel Disease
08/09/2007US20070185200 Screen for pre-eclampsia
08/09/2007US20070185074 A kit containing 4',5'-bis(2-arsa-1,3-dithiolan-2-yl)fluorescein a nucleic acid vector encoding a fusion protein of a target and a carrier polypeptide; intermolecular labeling with high specificity and reversibility; enzyme immunoassays
08/09/2007US20070185048 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders
08/09/2007US20070185031 Reducing polyglutamine-based aggregation
08/09/2007US20070185025 Filoviral immunosuppressive peptides and uses thereof
08/09/2007US20070185024 Systems and methods for screening for modulators of neural differentiation
08/09/2007US20070185021 Diabetogenic epitopes
08/09/2007US20070185020 Methods and compositions for treating disorders of the extracellular matrix
08/09/2007US20070185010 Novel Polypeptide Hormone Phosphatonin
08/09/2007US20070184559 Method and compounds for the fluorescent labelling of biomolecules and polymer particles
08/09/2007US20070184558 On-site immunoassaying of ruminants and ungulate animals by testing for the presence, absence, or particular level of selected Antigens A and/or B and C in a sample from a female animal; resynchronizing breeding with breeding cycle times of one estrus cycle or shorter; animal husbandry; efficiency
08/09/2007US20070184556 On-line monitoring method and device for a fossil fuel converter apparatus
08/09/2007US20070184555 Chemical markers
08/09/2007US20070184554 Biomarker of improved intestinal function
08/09/2007US20070184537 Method for the linkage of bifunctional chelating agents and (radioactive) transition metal complexes to proteins and peptides
08/09/2007US20070184515 Method to determine 3-d elemental composition and structure of biological and organic materials via atom probe microscopy
08/09/2007US20070184512 Mass spectrometry techniques for determining the status of sepsis in an individual
08/09/2007US20070184509 Using variation in reporter expression as assay for monitoring kinase and/or phosphatase activity
08/09/2007US20070184507 Methods for predicting outcome in traumatic brain injury
08/09/2007US20070184506 Immunological test element with improved control zone
08/09/2007US20070184505 Method for stabilization of proteins in solution
08/09/2007US20070184504 Assay for anti-INGAP antibodies
08/09/2007US20070184503 Contacting the sample with Cytochrome c (Cyt c) on a substrate where Cyt c binds to leucine-rich alpha-2-glycoprotein-1 (LRG); contacting bound components with an antibody/antibody fragment specific for LRG and detecting them; sensitivity; diagnosis/medical/; cancer; viral infections; viral diseases
08/09/2007US20070184502 Method of diagnosing Sjogren's syndrome
08/09/2007US20070184501 Blocker reagent for reduction of heterophile interferences
08/09/2007US20070184500 Host Receptor for Pathogenic Bacteria
08/09/2007US20070184499 Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
08/09/2007US20070184498 Protein RS15A as a marker for colorectal cancer
08/09/2007US20070184497 Clinical diagnostic reagent and diagnostic method for testing infection of adult taenia solium and taenia saginata
08/09/2007US20070184496 Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
08/09/2007US20070184495 Rapid nasal assay kit
08/09/2007US20070184494 receptacle, porous membrane, and binding agent; immunoassay
08/09/2007US20070184493 Visualization and quantitation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markers
08/09/2007US20070184492 Delayed and diffused flow rapid confirmatory immunological testing apparatus and method
08/09/2007US20070184491 Dendritic chemiluminescent substrates
08/09/2007US20070184490 Neuronal nicotinic receptor ligands and their use
08/09/2007US20070184488 Beta-secretase substrates and uses thereof
08/09/2007US20070184486 Diagnosis or treatment of endothelial cell dysfunction related diseases
08/09/2007US20070184485 Method of diagnosing diseases relating to endometriosis
08/09/2007US20070184484 Anti-abnormal type prion monoclonal antibody, process for producing the same, and immunoassay of abnormal type prion protein using the same
08/09/2007US20070184483 Biochemical analysis unit and method of producing thereof
08/09/2007US20070184480 C-terminal 28kDa endostatin-spanning proteolytic fragment for use in prevention and treatment of inflammation and cell proliferative disorders
08/09/2007US20070184476 Biomarkers for liver fibrotic injury
08/09/2007US20070184475 Sequence determination by direct detection
08/09/2007US20070184471 Analyte assay using particulate labels
08/09/2007US20070184469 nine residue peptides (ApoptoM) from flavivirus M ectodomain able to modulate specifically the apoptotic activity of diverse flavivirus; use for the treatment and/or the prevention of flavivirus-linked infections and cancers
08/09/2007US20070184461 Novel Polypeptide Hormone Phosphatonin
08/09/2007US20070184459 Methods of inhibiting cancer growth by binding to nuclear receptors
08/09/2007US20070184455 Evaluation of spectra
08/09/2007US20070184453 Fret process
08/09/2007US20070184450 Agents for and method of quantifying binding
08/09/2007US20070184446 Method of stretching single-stranded nucleic acid, single-stranded nucleic acid stretching system and dna chip
08/09/2007US20070184445 Photochromic relaxation kinetic method
08/09/2007US20070184444 Compositions and methods for the treatment of immune related diseases
08/09/2007US20070184443 Streptococcus pneumoniae knockout mutants
08/09/2007US20070184440 Methods of screening for useful proteins
08/09/2007US20070184439 Markers for detection of gastric cancer
08/09/2007US20070184435 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
08/09/2007US20070184433 Microparticle based biochip systems and uses thereof
08/09/2007US20070184432 Having a structure whereby, in the step of injecting a liquid sample into a microwell for holding a sample to be reacted, analyzed, detected, etc., overflow of the sample or the migration thereof into another well connected thereto can be prevented and position of sample in microwell can be adjusted
08/09/2007US20070184430 Method for analysing a tissue sample
08/09/2007US20070184429 conjugated fluorescent dyes with a steroid; 3-oxo-N-(2-{[6-(9-oxoacridin-10(9H)-yl)hexanoyl]amino}ethyl)androst-4-ene-17-carboxamide; drug screening a test agent which modulate aromatase activity
08/09/2007US20070184074 Fusion proteins of Mycobacterium tuberculosis
08/09/2007US20070184054 polynucleotide encoding oocyst sporocyst protein (EtOs22); for finding active compounds for treating an infection with Eimeria
08/09/2007US20070184048 Re-targeted toxin conjugates
08/09/2007US20070184042 Method of cancer treatment by p53 protein control
08/09/2007US20070184036 Isolated cd4+ t cells defined by cmrf-35
08/09/2007US20070184026 Methods, Agents, and Compound Screening Assays for Inducing Differentiation of Undifferentiated Mammalian Cells into Osteoblasts
08/09/2007US20070184021 Use of caspase inhibitors as a therapeutic agent against radiation-induced injury
08/09/2007US20070183970 Chimeric, human and humanized anti-granulocyte antibodies and methods of use
08/09/2007US20070183969 Cln101 antibody compositions and methods of use alone and in combination with prostate specific antigen and other cancer markers
08/09/2007US20070183936 Apparatus and methods for evaluating the barrier properties of a membrane
08/09/2007US20070183929 Total organic carbon analysis
08/09/2007US20070183927 System and method for contamination detection within sealed containers
08/09/2007US20070183925 Handheld apparatus for analysis with a conveyance path for test elements
08/09/2007US20070181424 biosensors; immobilization; complementary metal oxide semiconductors
08/09/2007US20070181423 Gas sensor
08/09/2007US20070181067 Milk conveyer device
08/09/2007US20070180938 Method and device for determining at least one dynamic property of a deformable solid or fluid material
08/09/2007US20070180895 Hair coloring system and test device capable of being used in such a system
08/09/2007US20070180892 Sensor arrangement
08/09/2007DE202007007707U1 Messkassette Measuring tape
08/09/2007DE202007006240U1 Messvorrichtung zur Bestimmung der Restfeuchtigkeit einer Textilbahn Measuring device for determining the residual moisture of a textile web